RecruitingNCT06121284
D-cycloserine with accelerated iTBS for suicidal thoughts in young adults
About this title
Read the official source — NCT06121284Medication studyAges 18–24CanadaSuicide prevention
Understand this study
Who could participate?
Listed age limits: 18 years to 24 years.
- Listed locations
- CalgarySee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 11, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 54
- Sponsor
- University of Calgary
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Device, Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 18 Years to 24 Years
- Official registry ID
- NCT06121284
- Official title
Show the full official title
A Randomized Placebo-controlled Trial of Adjunctive D-Cycloserine and Accelerated Intermittent Theta Burst Stimulation for Emerging Adults With Suicidal Ideation
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Calgary
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Calgary, a university.
Does this study involve medication?
Yes. The study involves medication, including D-Cycloserine and Placebo oral tablet.
Who can participate?
Listed age limits: 18 years to 24 years.
Is this study still recruiting?
The registry lists this study as recruiting.
